Prasugrel with percutaneous coronary intervention for treating acute coronary syndrome (review of TA182): evaluation report

01.  NICE’s response to comments on the Appraisal Consultation Document (ACD)

02.  Consultee comments on the ACD - Lilly UK

03.  Consultee comments on the ACD – Pumping Marvellous Foundation

04.  Consultee comments on the ACD – Pumping Marvellous Foundation 2

05.  Consultee comments on the ACD – Royal College of Nursing

06.  Commentator comments on the ACD – AstraZeneca

07.  Commentator comments on the ACD – Healthcare Improvement Scotland

08.  Public comments on the ACD received through the NICE website

Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.

This page was last updated: 18 June 2014